Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Clinical Update.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33346558.
- Also identified by DOI 10.1097/SAP.0000000000002618.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a recently recognized malignancy of T-lymphocytes that is linked to certain types of textured breast implants. Although rare, the increasing awareness of the disease is resulting in more case reports and heightened anxiety in patients with textured breast implants. This review aims to summarize the available BIA-ALCL data, including the existing theories of etiopathogenesis, the diagnostic work-up for BIA-ALCL patients, BIA-ALCL treatment recommendations, the epidemiologic challenges, and the current opinions surrounding the use of textured breast implants.
Medical subject headings
- Breast Implantation
- Breast Implants
- Breast Neoplasms
- Lymphoma, Large-Cell, Anaplastic